Compare ELTX & RBKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELTX | RBKB |
|---|---|---|
| Founded | 2011 | 1860 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.1M | 132.4M |
| IPO Year | 2014 | 2018 |
| Metric | ELTX | RBKB |
|---|---|---|
| Price | $8.83 | $15.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 133.0K | 14.8K |
| Earning Date | 01-01-0001 | 04-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.94 | N/A |
| EPS | N/A | ★ 0.70 |
| Revenue | $2,301,000.00 | ★ $3,002,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $21.83 |
| Revenue Growth | N/A | ★ 4.24 |
| 52 Week Low | $4.60 | $9.31 |
| 52 Week High | $12.62 | $16.14 |
| Indicator | ELTX | RBKB |
|---|---|---|
| Relative Strength Index (RSI) | 57.25 | 73.92 |
| Support Level | $8.05 | $12.09 |
| Resistance Level | $9.61 | $15.82 |
| Average True Range (ATR) | 0.81 | 0.59 |
| MACD | 0.07 | 0.35 |
| Stochastic Oscillator | 62.04 | 82.41 |
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank which provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management (RAM). The Bank's primary business activity is accepting deposits from the general public and using those funds to originate indirect automobile loans (automobile loans referred by automobile dealerships), commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and one-to four-family residential real estate loans, and to purchase investment securities.